| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 370.31B | 359.46B | 336.91B | 282.09B | 273.61B |
| Gross Profit | 118.94B | 103.82B | 95.20B | 75.79B | 74.56B |
| EBITDA | 40.25B | 37.91B | 39.70B | 26.52B | 24.78B |
| Net Income | 20.28B | 13.02B | 16.23B | 5.87B | 2.15B |
Balance Sheet | |||||
| Total Assets | 313.34B | 316.82B | 299.36B | 280.81B | 264.33B |
| Cash, Cash Equivalents and Short-Term Investments | 48.60B | 57.87B | 56.19B | 48.71B | 59.64B |
| Total Debt | 50.37B | 57.30B | 62.48B | 69.84B | 75.59B |
| Total Liabilities | 181.93B | 195.60B | 195.63B | 196.85B | 195.80B |
| Stockholders Equity | 125.10B | 114.80B | 98.81B | 79.50B | 64.64B |
Cash Flow | |||||
| Free Cash Flow | 18.74B | 12.16B | 10.79B | -8.90B | 21.92B |
| Operating Cash Flow | 31.45B | 33.17B | 26.61B | 7.06B | 35.83B |
| Investing Cash Flow | -21.55B | -16.06B | -7.33B | -9.80B | -11.80B |
| Financing Cash Flow | -18.79B | -19.35B | -14.03B | -11.27B | -5.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥358.98B | 18.77 | 5.53% | 3.55% | -5.43% | 55.21% | |
73 Outperform | $5.12T | 24.67 | 6.73% | 1.99% | -6.96% | -7.22% | |
73 Outperform | ¥20.44T | 18.00 | 14.45% | 0.55% | -2.86% | 5.93% | |
66 Neutral | ¥182.12B | 9.85 | 13.53% | 1.34% | 0.48% | -1.86% | |
66 Neutral | ¥93.69B | 18.88 | ― | 1.99% | 3.71% | -3.32% | |
64 Neutral | ¥3.60T | 34.81 | 1.37% | 2.29% | -0.51% | -45.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |